← FDA Drug Approvals (Drugs@FDA)
SUGAMMADEX SODIUM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ASPIRO · Approved 2023-06-09
Drug application
- FDA Application #
ANDA214337- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- SUGAMMADEX SODIUM
- Generic name
- Sugammadex Sodium
- Active ingredients
- SUGAMMADEX SODIUM
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- ASPIRO
- First approval
- 2023-06-09
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown